We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Drug Abuse by Anesthesiologists

By HospiMedica staff writers
Posted on 14 Oct 2002
A survey has found that substance abuse among anesthesiologists is a continuing problem, with around 1% of faculty members and 1.6% of residents admitting use of a controlled substance. More...
The survey was a component of a study published in the October 2002 issue of Anesthesia and Analgesia.

The study showed that improved control of operating room medications and increased education have not helped to cut the rate of substance abuse. However, the researchers emphasize that all use of a controlled substance took place outside of the operating room setting during the doctors' personal time, and there were no reports of patient harm as a result of impaired functioning. The survey was sent to the chairpersons of anesthesiology at 133 US academic medical centers, and 123 responded. The responses indicated that the most commonly abused medication was fentanyl.

"Fentanyl is a narcotic that works much quicker than morphine and provides very effective pain relief,” said John Booth, M.D., an anesthesiologist at Duke University Medical Center (Durham, NC, USA) and lead author of the study. "But, like other drugs of the same class, it is addictive and over time, larger doses are needed to achieve the same effect.”

Dr. Booth suggests that one possible solution is drug testing, now common in many workplace settings. He also believes a national databank of all doctors who are having substance abuse problems should be established to identify at-risk doctors in order to get them some help before it is too late.





Related Links:
Duke University Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.